Showing results (61-70 of 265) with videos related to

Sort By:
Pageof 27
Gastroenterology|January 7, 2022
Time to Revisit Disease Classification in Inflammatory Bowel Disease: Is the Current Classification of Inflammatory Bowel Disease Good Enough for Optimal Clinical Management?Bram Verstockt, Brian Bressler, Helena Martinez-Lozano, et al.
International Journal of Molecular Sciences|January 5, 2021
Modeling Intestinal Epithelial Response to Interferon-γ in Induced Pluripotent Stem Cell-Derived Human Intestinal OrganoidsMichael J Workman, Elissa Troisi, Stephan R Targan, et al.
Inflammatory Bowel Diseases|August 1, 2007
TNFSF15 is an ethnic-specific IBD geneYoana Picornell, Ling Mei, Kent Taylor, et al.
BMJ (Clinical Research Ed.)|July 27, 2002
The "jaundice hotline" for the rapid assessment of patients with jaundiceJonathan Mitchell, Hyder Hussaini, Dermot McGovern, et al.
Clinical Immunology (Orlando, Fla.)|December 25, 2016
NK cells are biologic and biochemical targets of 6-mercaptopurine in Crohn's disease patientsSusy Yusung, Dermot McGovern, Lin Lin, et al.
Inflammatory Bowel Diseases|August 30, 2014
IFNG rs1861494 polymorphism is associated with IBD disease severity and functional changes in both IFNG methylation and protein secretionRivkah Gonsky, Richard L Deem, Carol J Landers, et al.
Inflammatory Bowel Diseases|October 29, 2005
State of the art: IBD therapy and clinical trials in IBDKim L Isaacs, James D Lewis, William J Sandborn, et al.
The American Journal of Gastroenterology|February 26, 2009
Transient cytokine-induced liver injury following administration of the humanized anti-CD3 antibody visilizumab (HuM291) in Crohn's diseaseDaniel C Baumgart, James N Lowder, Stephan R Targan, et al.
The American Journal of Gastroenterology|June 18, 2003
Thioguanine: a potential alternate thiopurine for IBD patients allergic to 6-mercaptopurine or azathioprineMarla C Dubinsky, Edward J Feldman, Maria T Abreu, et al.
Inflammatory Bowel Diseases|December 17, 2021
Development of a Personalized Intestinal Fibrosis Model Using Human Intestinal Organoids Derived From Induced Pluripotent Stem CellsHannah Q Estrada, Shachi Patel, Shervin Rabizadeh, et al.
Pageof 27